Free tool
Stocks listed on Nasdaq CM
We cover 108 companies listed on Nasdaq CM. The median market value in the group is $419.61M. Across the group, the median move over the past trading day is −0.38%. 67% of the 107 with a 200-day average trade above it. Price change over the past year runs from −38.4% to +217.5% across the middle 80 percent of the group, with a median of +39.7%.
Other lists in this group
Table
108 of 1,344 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| TGTX | TG Therapeutics, Inc. Common Stock | $8.42B | Mid cap | +92.61% | Nov 2, 2026 |
| BLTE | Belite Bio, Inc | $6.31B | Mid cap | +144.07% | Nov 9, 2026 |
| LQDA | Liquidia Corporation | $6.31B | Mid cap | +154.86% | Nov 3, 2026 |
| DNTH | Dianthus Therapeutics, Inc. | $6.13B | Mid cap | +356.93% | Nov 5, 2026 |
| CELC | Celcuity Inc. | $4.65B | Mid cap | +90.31% | Nov 11, 2026 |
| VKTX | Viking Therapeutics, Inc. | $4.01B | Mid cap | +29.15% | Oct 28, 2026 |
| PLSE | Pulse Biosciences, Inc. | $3.43B | Mid cap | +203.47% | Nov 5, 2026 |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +188.94% | Nov 5, 2026 |
| CLDX | Celldex Therapeutics, Inc. | $3.19B | Mid cap | +79.51% | Nov 9, 2026 |
| SLS | SELLAS Life Sciences Group, Inc. | $2.77B | Mid cap | +615.10% | Nov 11, 2026 |
| VRDN | Viridian Therapeutics, Inc. | $2.75B | Mid cap | +30.71% | Nov 5, 2026 |
| RGC | Regencell Bioscience Holdings Limited | $2.72B | Mid cap | −61.38% | Oct 28, 2026 |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +219.58% | Oct 28, 2026 |
| NKTR | Nektar Therapeutics | $2.52B | Mid cap | +151.95% | Nov 12, 2026 |
| UFPT | UFP Technologies, Inc. | $2.36B | Mid cap | +41.94% | Nov 2, 2026 |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% | Oct 27, 2026 |
| ESTA | Establishment Labs Holdings Inc. | $2.15B | Mid cap | +70.71% | Nov 4, 2026 |
| PIII | P3 Health Partners Inc. | $1.98B | Small cap | +26.37% | Nov 12, 2026 |
| ASTH | Astrana Health, Inc. | $1.92B | Small cap | +23.71% | Nov 5, 2026 |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +804.46% | Nov 5, 2026 |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.50% | Nov 5, 2026 |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% | Nov 9, 2026 |
| IMTX | Immatics N.V. | $1.41B | Small cap | +74.63% | Nov 17, 2026 |
| JBIO | Jade Biosciences, Inc. | $1.39B | Small cap | +168.30% | Nov 12, 2026 |
| DRTS | Alpha Tau Medical Ltd. | $1.38B | Small cap | +343.92% | Nov 19, 2026 |
| NUTX | Nutex Health Inc. | $1.34B | Small cap | +118.22% | Nov 5, 2026 |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.82% | Nov 5, 2026 |
| ODTX | Odyssey Therapeutics, Inc. | $1.23B | Small cap | +56.03% | Nov 5, 2026 |
| AVTX | Avalo Therapeutics, Inc. | $1.10B | Small cap | +112.95% | Nov 12, 2026 |
| LXRX | Lexicon Pharmaceuticals, Inc. | $1.04B | Small cap | +104.42% | Nov 5, 2026 |
| DBVT | DBV Technologies S.A. | $940.80M | Small cap | +53.00% | Oct 28, 2026 |
| TALK | Talkspace, Inc. | $870.57M | Small cap | +93.73% | Oct 29, 2026 |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% | Nov 5, 2026 |
| NVCT | Nuvectis Pharma, Inc. | $816.10M | Small cap | +275.94% | Nov 3, 2026 |
| AHCO | AdaptHealth Corp. | $771.43M | Small cap | −38.44% | Nov 3, 2026 |
| MNPR | Monopar Therapeutics Inc. | $763.31M | Small cap | +226.69% | Nov 12, 2026 |
| SSII | SS Innovations International, Inc. | $715.38M | Small cap | −50.55% | Oct 27, 2026 |
| GYRE | Gyre Therapeutics, Inc. | $705.12M | Small cap | −18.00% | Nov 5, 2026 |
| PROK | ProKidney Corp. | $694.58M | Small cap | −30.12% | Nov 9, 2026 |
| MDXG | MiMedx Group, Inc. | $644.26M | Small cap | −38.35% | Oct 28, 2026 |
| VSTM | Verastem, Inc. | $641.19M | Small cap | −20.45% | Nov 3, 2026 |
| ZURA | Zura Bio Limited | $574.02M | Small cap | +177.31% | Nov 12, 2026 |
| DCTH | Delcath Systems, Inc. | $569.06M | Small cap | +49.91% | Nov 3, 2026 |
| OVID | Ovid Therapeutics Inc. | $562.46M | Small cap | +128.57% | Nov 11, 2026 |
| SRTA | Strata Critical Medical, Inc. | $541.42M | Small cap | +33.62% | Nov 9, 2026 |
| TOI | Starling Oncology Inc | $512.91M | Small cap | +79.19% | Nov 9, 2026 |
| CLPT | ClearPoint Neuro, Inc. | $499.35M | Small cap | +53.85% | Nov 5, 2026 |
| EPRX | Eupraxia Pharmaceuticals Inc. | $490.26M | Small cap | +40.72% | Nov 3, 2026 |
| RLMD | Relmada Therapeutics, Inc. | $485.35M | Small cap | +579.10% | Nov 12, 2026 |
| RZLT | Rezolute, Inc. | $485.31M | Small cap | −30.00% | Sep 16, 2026 |
| OCGN | Ocugen, Inc. | $478.15M | Small cap | +35.58% | Nov 5, 2026 |
| BNTC | Benitec Biopharma Inc. | $442.48M | Small cap | +0.16% | Sep 22, 2026 |
| CMPX | Compass Therapeutics, Inc. | $437.61M | Small cap | −25.91% | Nov 5, 2026 |
| FENC | Fennec Pharmaceuticals Inc. | $426.77M | Small cap | +34.62% | Nov 12, 2026 |
| XFOR | X4 Pharmaceuticals, Inc. | $412.45M | Small cap | −1.42% | Nov 5, 2026 |
| IPSC | Century Therapeutics, Inc. | $392.93M | Small cap | +315.53% | Nov 12, 2026 |
| AGEN | Agenus Inc. | $371.33M | Small cap | +81.72% | Nov 5, 2026 |
| DMAC | DiaMedica Therapeutics Inc. | $361.30M | Small cap | +12.04% | Nov 11, 2026 |
| VMD | Viemed Healthcare, Inc. | $355.36M | Small cap | +29.94% | Nov 4, 2026 |
| SABS | SAB Biotherapeutics, Inc. | $353.03M | Small cap | +83.02% | Nov 12, 2026 |
| IKT | Inhibikase Therapeutics, Inc. | $347.44M | Small cap | +39.11% | Nov 13, 2026 |
| ABEO | Abeona Therapeutics Inc. | $343.68M | Small cap | −12.90% | Nov 11, 2026 |
| PRQR | ProQR Therapeutics N.V. | $331.63M | Small cap | +6.33% | Nov 5, 2026 |
| RCEL | AVITA Medical, Inc. | $327.52M | Small cap | +133.77% | Nov 5, 2026 |
| SMTI | Sanara MedTech Inc. | $318.55M | Small cap | +2.09% | Nov 11, 2026 |
| IRD | Opus Genetics, Inc. | $316.14M | Small cap | +216.67% | Nov 11, 2026 |
| AMRN | Amarin Corporation plc | $301.43M | Small cap | −7.08% | Oct 28, 2026 |
| CV | CapsoVision, Inc. | $291.27M | Small cap | +46.97% | Nov 12, 2026 |
| WHWK | Whitehawk Therapeutics, Inc. | $275.92M | Small cap | +167.40% | Nov 5, 2026 |
| ELDN | Eledon Pharmaceuticals, Inc. | $272.22M | Small cap | +29.84% | Nov 13, 2026 |
| CGEN | Compugen Ltd. | $271.86M | Small cap | +93.20% | Nov 9, 2026 |
| GLSI | Greenwich LifeSciences, Inc. | $267.58M | Small cap | +56.21% | Nov 12, 2026 |
| NAGE | Niagen Bioscience, Inc. | $260.44M | Small cap | −66.22% | Nov 3, 2026 |
| SLGL | Sol-Gel Technologies Ltd. | $260.05M | Small cap | +261.87% | Nov 19, 2026 |
| PROF | Profound Medical Corp. | $259.75M | Small cap | +57.30% | Nov 12, 2026 |
| ACB | Aurora Cannabis Inc. | $253.24M | Small cap | −24.95% | Nov 4, 2026 |
| AKBA | Akebia Therapeutics, Inc. | $251.20M | Small cap | −69.88% | Nov 9, 2026 |
| CRDL | Cardiol Therapeutics Inc. | $250.00M | Small cap | +91.07% | Nov 12, 2026 |
| SY | So-Young International Inc. | $240.91M | Small cap | −38.93% | Aug 31, 2026 |
| DTIL | Precision BioSciences, Inc. | $234.34M | Small cap | +69.46% | Nov 2, 2026 |
| ORGO | Organogenesis Holdings Inc. | $225.18M | Small cap | −63.84% | Nov 5, 2026 |
| IMUX | Immunic, Inc. | $225.00M | Small cap | +92.87% | Nov 12, 2026 |
| NGEN | NervGen Pharma Corp. | $223.65M | Small cap | −8.30% | Nov 23, 2026 |
| HITI | High Tide Inc. | $221.43M | Small cap | −30.00% | Sep 14, 2026 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $218.56M | Small cap | +7.93% | Nov 16, 2026 |
| ORMP | Oramed Pharmaceuticals Inc. | $218.55M | Small cap | +159.19% | Nov 12, 2026 |
| DERM | Journey Medical Corporation | $212.95M | Small cap | +0.87% | Nov 11, 2026 |
| ACOG | Alpha Cognition Inc. | $204.93M | Small cap | +14.20% | Nov 12, 2026 |
| PDEX | Pro-Dex, Inc. | $203.83M | Small cap | +40.31% | Aug 27, 2026 |
| KRRO | Korro Bio, Inc. | $201.45M | Small cap | −36.61% | Nov 12, 2026 |
| LUCD | Lucid Diagnostics Inc. | $185.35M | Small cap | −22.96% | Nov 11, 2026 |
| TNYA | Tenaya Therapeutics, Inc. | $156.11M | Small cap | −36.71% | Nov 11, 2026 |
| NRXP | NRx Pharmaceuticals, Inc. | $149.80M | Small cap | +34.11% | Nov 12, 2026 |
| KRMD | KORU Medical Systems, Inc. | $148.21M | Small cap | −24.47% | Nov 11, 2026 |
| OPRX | OptimizeRx Corporation | $145.98M | Small cap | −55.79% | Nov 5, 2026 |
| IMDX | Insight Molecular Diagnostics Inc. | $145.30M | Small cap | +73.39% | Nov 9, 2026 |
| HURA | TuHURA Biosciences, Inc. | $135.74M | Small cap | −26.55% | Nov 13, 2026 |
| INO | Inovio Pharmaceuticals, Inc. | $134.42M | Small cap | −47.15% | Nov 10, 2026 |
| ENGN | enGene Therapeutics Inc. | $130.63M | Small cap | −55.07% | Sep 14, 2026 |
| CBUS | Cibus, Inc. | $128.40M | Small cap | +27.27% | Nov 12, 2026 |
| VANI | Vivani Medical, Inc. | $127.64M | Small cap | +15.98% | Nov 12, 2026 |
| ANIX | Anixa Biosciences, Inc. | $122.65M | Small cap | +22.20% | Sep 9, 2026 |
| JYNT | The Joint Corp. | $120.78M | Small cap | −20.19% | Nov 5, 2026 |
| COYA | Coya Therapeutics, Inc. | $114.24M | Small cap | −25.76% | Nov 11, 2026 |
| NAUT | Nautilus Biotechnology, Inc. | $111.99M | Small cap | +33.34% | Oct 27, 2026 |
| ONCY | Oncolytics Biotech Inc. | $109.10M | Small cap | −19.28% | Nov 16, 2026 |
| LNSR | LENSAR, Inc. | $106.27M | Small cap | −29.04% | Nov 12, 2026 |
| PYPD | PolyPid Ltd. | $103.79M | Small cap | +49.42% | Nov 11, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.